Physician profile
Juan E Martin
NPI 1487632220
$1,110.73
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $322 · 2021: $175 · 2022: $136.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $634.92 | 2019-2021 | |
| Bolton Medical INC | $101.58 | 2021-2022 | |
| Biom'Up France Sas | $77.64 | 2020-2021 | |
| Medtronic Vascular, INC. | $61.26 | 2019-2020 | |
| Medtronic, INC. | $53.55 | 2021-2022 | |
| Kls-Martin L.P. | $42.08 | 2019-2020 | |
| Cvrx, INC. | $38.50 | 2021 | |
| Getinge USA Sales, LLC | $25.67 | 2020 | |
| Ethicon US, LLC | $25.04 | 2022 | |
| Abiomed | $23.72 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.89 | 2019 | |
| Portola Pharmaceuticals, LLC | $11.88 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.